About Etiometry
Etiometry is a private company based in Boston, Massachusetts. It has reported $15,648,231 raised in three offerings on Form D since October 2017. Its chief executive is Shane Cooke.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2022 | Apr 10, 2023amended Apr 2, 2024 | $10,000,000of $14.0M target | 7 | $1.4M | Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 16, 2020 | Oct 1, 2020amended Mar 30, 2021 | $5,148,231of $9.0M target | 24 | $214K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 29, 2017 | Oct 16, 2017 | $500,000of $5.0M target | 3 | $166K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $15,648,231 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Etiometry's Form D filed Apr 2, 2024.
Earlier filings also listed Bradley Rosenblum (chief financial officer, last listed Mar 2021), Peter Rock (chief financial officer and director, last listed Oct 2017), Nelson Stacks (director, last listed Oct 2017), Jesse Lock (chief medical officer and director, last listed Oct 2017) and Eric Meyers (director, last listed Oct 2017).